Butterfield-Cowper Jill M
HealthTrust Supply Chain, Nashville, TN.
HCA Healthc J Med. 2023 Apr 28;4(2):95-104. doi: 10.36518/2689-0216.1560. eCollection 2023.
Description A core element of hospital antibiotic stewardship programs is the tracking of outcomes. It is recommended that hospitals do this by reporting to the National Healthcare Safety Network (NHSN) Antimicrobial Use (AU) Option. With this, hospitals can access the Standardized Antimicrobial Administration Ratio (SAAR) for various antibiotic groupings and locations. While there are benefits to the SAAR, several limitations reduce the interpretation and utility of SAAR values. In particular, the SAAR cannot inform users of antimicrobial appropriateness. This article describes an antimicrobial days of therapy (DOT) report that was developed by a tele-stewardship infectious diseases pharmacist. This article proposes that a DOT report, such as the one described, is used in combination with SAAR values to better assess where improvements in antimicrobial prescribing are needed and track the progress of interventions. If not reporting to the NHSN AU Option, this type of report can help meet antimicrobial stewardship standards from The Joint Commission.
描述 医院抗生素管理计划的一个核心要素是对结果进行追踪。建议医院通过向国家医疗安全网络(NHSN)抗菌药物使用(AU)选项报告来做到这一点。通过这种方式,医院可以获取各种抗生素分组和地点的标准化抗菌药物给药率(SAAR)。虽然SAAR有其益处,但一些局限性降低了SAAR值的解释和效用。特别是,SAAR无法告知使用者抗菌药物的合理性。本文介绍了由远程管理传染病药剂师制定的抗菌药物治疗天数(DOT)报告。本文提出,像所描述的这种DOT报告应与SAAR值结合使用,以更好地评估在哪些方面需要改进抗菌药物处方并追踪干预措施的进展。如果未向NHSN AU选项报告,这类报告有助于符合联合委员会的抗菌药物管理标准。